Cancer survivors may experience more challenges to adopt a child
the ONA take:
According to a recent study published online ahead of print in the journal Cancer, researchers have found that cancer survivors' options for adoption may be limited by adoption agencies' policies.
Many young cancer survivors often opt to adopt to a child after cancer and cancer therapies leave some patients infertile; however, not only is adoption a long and costly process, but some adoption agencies also have policies that may prevent cancer survivors from being able to adopt.
For the study, oncology nurses participating in a training program contacted and interviewed adoption agencies about the costs and requirements for adoption. the nurses found that adoption fees ranged from $3,000 to $75,000. They also found that a few agencies believed it could be discouraging for a birth mother to have an adoptive parent with a history of cancer, while others reported that a history of cancer could make birth mothers feel optimistic and confident.
The study also helped oncology nurses to become more knowledgeable about the challenges of adoption in cancer survivors, and study authors hope that this experience will help them to better inform their patients on parenthood options in the future.
Researchers have found that cancer survivors' options for adoption may be limited by adoption agencies' policies.
Sign Up for Free e-newsletters
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- Age Not a Deterrent to Immunotherapy for Malignant Melanoma
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|